Aggregation of polyglutamine-expanded ataxin-3 sequesters its specific interacting partners into inclusions: Implication in a loss-of-function pathology

Scientific Reports

Volumn 4, Issue , 2014, Pages

  Yang, Hui ^a   Li, Jing Jing ^a   Liu, Shuai ^a   Zhao, Jian ^a   Jiang, Ya Jun ^a   Song, Ai Xin ^a   Hu, Hong Yu ^a  

^a INSTITUTE OF GEOLOGY AND GEOPHYSICS   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATASE; ATXN3 PROTEIN, HUMAN; CDC48 PROTEIN; CELL CYCLE PROTEIN; NERVE PROTEIN; NUCLEAR PROTEIN; PEPTIDE; POLYGLUTAMINE; REPRESSOR PROTEIN; UBIQUITIN;

CELL INCLUSION; CHEMISTRY; DEGENERATIVE DISEASE; GENETICS; HUMAN; METABOLISM; PATHOLOGY; PROTEIN CONFORMATION; PROTEIN FOLDING; PROTEIN MULTIMERIZATION; TRINUCLEOTIDE REPEAT;

ADENOSINE TRIPHOSPHATASES; CELL CYCLE PROTEINS; HUMANS; INCLUSION BODIES; NERVE TISSUE PROTEINS; NEURODEGENERATIVE DISEASES; NUCLEAR PROTEINS; PEPTIDES; PROTEIN CONFORMATION; PROTEIN FOLDING; PROTEIN MULTIMERIZATION; REPRESSOR PROTEINS; TRINUCLEOTIDE REPEAT EXPANSION; UBIQUITIN;

EID: 84923380331     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep06410     Document Type: Article

References (60)

1. Chiti, F. & Dobson, C. M. Protein misfolding, functional amyloid, and human disease. Annu Rev Biochem 75, 333-366 (2006).
2. Zoghbi, H. Y. & Orr, H. T. Glutamine repeats and neurodegeneration. Annu Rev Neurosci 23, 217-247 (2000).
3. Orr, H. T. & Zoghbi, H. Y. Trinucleotide repeat disorders. Annu Rev Neurosci 30, 575-621 (2007).
4. Blum, E. S., Schwendeman, A. R. & Shaham, S. PolyQ disease: misfiring of a developmental cell death program? Trends Cell Biol 23, 168-174 (2013).
5. Perutz, M. F., Johnson, T., Suzuki, M. & Finch, J. T. Glutamine repeats as polar zippers: their possible role in inherited neurodegenerative diseases. Proc Natl Acad Sci U S A 91, 5355-5358 (1994).
6. Chen, S., Ferrone, F. A. &Wetzel, R. Huntington's disease age-of-onset linked to polyglutamine aggregation nucleation. Proc Natl Acad Sci U S A 99, 11884-11889 (2002).
7. Arrasate, M., Mitra, S., Schweitzer, E. S., Segal, M. R. & Finkbeiner, S. Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal death. Nature 431, 805-810 (2004).
8. Ross, C. A. & Poirier, M. A. Protein aggregation and neurodegenerative disease. Nat Med 10 Suppl, S10-17 (2004).
9. Jiang, Y. J. et al. Interaction with polyglutamine-expanded huntingtin alters cellular distribution and RNA processing of huntingtin yeast two-hybrid protein A (HYPA). J Biol Chem 286, 25236-25245 (2011).
10. Olzscha, H. et al. Amyloid-like aggregates sequester numerous metastable proteins with essential cellular functions. Cell 144, 67-78 (2011).
11. Qin, Z. H. et al. Huntingtin bodies sequester vesicle-Associated proteins by a polyproline-dependent interaction. J Neurosci 24, 269-281 (2004).
12. McCampbell, A. et al. CREB-binding protein sequestration by expanded polyglutamine. Hum Mol Genet 9, 2197-2202 (2000).
13. Paulson, H. L. et al. Intranuclear inclusions of expanded polyglutamine protein in spinocerebellar ataxia type 3. Neuron 19, 333-344 (1997).
14. Park, S. H. et al. PolyQ proteins interfere with nuclear degradation of cytosolic proteins by sequestering the Sis1p chaperone. Cell 154, 134-145 (2013).
15. Chai, Y., Shao, J., Miller, V. M., Williams, A. & Paulson, H. L. Live-cell imaging reveals divergent intracellular dynamics of polyglutamine disease proteins and supports a sequestration model of pathogenesis. Proc Natl Acad Sci U S A 99, 9310-9315 (2002).
16. Fujita, K. et al. A functional deficiency of TERA/VCP/p97 contributes to impaired DNA repair in multiple polyglutamine diseases. Nat Commun 4, 1816 (2013).
17. Chai, Y., Berke, S. S., Cohen, R. E. & Paulson, H. L. Poly-ubiquitin binding by the polyglutamine disease protein ataxin-3 links its normal function to protein surveillance pathways. J Biol Chem 279, 3605-3611 (2004).
18. Nicastro, G. et al. Understanding the role of the Josephin domain in the PolyUb binding and cleavage properties of ataxin-3. PLoS One 5, e12430 (2010).
19. Doss-Pepe, E. W., Stenroos, E. S., Johnson, W. G. & Madura, K. Ataxin-3 interactions with rad23 and valosin-containing protein and its associations with ubiquitin chains and the proteasome are consistent with a role in ubiquitinmediated proteolysis. Mol Cell Biol 23, 6469-6483 (2003).
20. Wang, Q., Li, L. & Ye, Y. Regulation of retrotranslocation by p97-Associated deubiquitinating enzyme ataxin-3. J Cell Biol 174, 963-971 (2006).
21. Zhong, X. & Pittman, R. N. Ataxin-3 binds VCP/p97 and regulates retrotranslocation of ERAD substrates. Hum Mol Genet 15, 2409-2420 (2006).
22. Goto, J. et al. Machado-Joseph disease gene products carrying different carboxyl termini. Neurosci Res 28, 373-377 (1997).
23. Berke, S. J., Chai, Y., Marrs, G. L., Wen, H. & Paulson, H. L. Defining the role of ubiquitin-interacting motifs in the polyglutamine disease protein, ataxin-3. J Biol Chem 280, 32026-32034 (2005).
24. Harris, G. M., Dodelzon, K., Gong, L., Gonzalez-Alegre, P. & Paulson, H. L. Splice isoforms of the polyglutamine disease protein ataxin-3 exhibit similar enzymatic yet different aggregation properties. PLoS One 5, e13695 (2010).
25. Song, A. X. et al. Structural transformation of the tandem ubiquitin-interacting motifs in ataxin-3 and their cooperative interactions with ubiquitin chains. PLoS One 5, e13202 (2010).
26. Nicastro, G. et al. The solution structure of the Josephin domain of ataxin-3: structural determinants for molecular recognition. Proc Natl Acad Sci U S A 102, 10493-10498 (2005).
27. Mao, Y. et al. Deubiquitinating function of ataxin-3: insights from the solution structure of the Josephin domain. Proc Natl Acad Sci U S A 102, 12700-12705 (2005).
28. Boeddrich,A. et al.An arginine/lysine-rich motif is crucial for VCP/p97-mediated modulation of ataxin-3 fibrillogenesis. EMBO J 25, 1547-1558 (2006).
29. Liu, S., Fu, Q. S., Zhao, J. & Hu, H. Y. Structural and mechanistic insights into the arginine/lysine-rich peptide motifs that interact with P97/VCP. Biochim Biophys Acta 1834, 2672-2678 (2013).
30. Maciel, P. et al. Improvement in the molecular diagnosis of Machado-Joseph disease. Arch Neurol 58, 1821-1827 (2001).
31. Seidel, K. et al. Axonal inclusions in spinocerebellar ataxia type 3. Acta Neuropathol 120, 449-460 (2010).
32. Hayashi, M., Kobayashi, K. & Furuta, H. Immunohistochemical study of neuronal intranuclear and cytoplasmic inclusions in Machado-Joseph disease. Psychiatry Clin Neurosci 57, 205-213 (2003).
33. Paulson, H. L. et al.Machado-Joseph disease gene product is a cytoplasmic protein widely expressed in brain. Ann Neurol 41, 453-462 (1997).
34. Chai, Y., Koppenhafer, S. L., Bonini, N. M. & Paulson, H. L. Analysis of the role of heat shock protein (Hsp) molecular chaperones in polyglutamine disease. J Neurosci 19, 10338-10347 (1999).
35. Chai, Y., Koppenhafer, S. L., Shoesmith, S. J., Perez, M. K. & Paulson, H. L. Evidence for proteasome involvement in polyglutamine disease: localization to nuclear inclusions in SCA3/MJD and suppression of polyglutamine aggregation in vitro. Hum Mol Genet 8, 673-682 (1999).
36. Schmidt, T. et al. Protein surveillance machinery in brains with spinocerebellar ataxia type 3: redistribution and differential recruitment of 26S proteasome subunits and chaperones to neuronal intranuclear inclusions. Ann Neurol 51, 302-310 (2002).
37. Mueller, T. et al. CK2-dependent phosphorylation determines cellular localization and stability of ataxin-3. Hum Mol Genet 18, 3334-3343 (2009).
38. Breuer, P., Haacke, A., Evert, B. O. & Wullner, U. Nuclear aggregation of polyglutamine-expanded ataxin-3: fragments escape the cytoplasmic quality control. J Biol Chem 285, 6532-6537 (2010).
39. Liu, S. et al.NEDD8 ultimate buster-1 long (NUB1L) protein promotes transfer of NEDD8 to proteasome for degradation through the P97UFD1/NPL4 complex. J Biol Chem 288, 31339-31349 (2013).
40. Ferro, A. et al. NEDD8: a new ataxin-3 interactor. Biochim Biophys Acta 1773, 1619-1627 (2007).
41. Nicastro, G. et al. Josephin domain of ataxin-3 contains two distinct ubiquitinbinding sites. Biopolymers 91, 1203-1214 (2009).
42. Jung, J., Xu, K., Lessing, D. & Bonini, N. M. Preventing Ataxin-3 protein cleavage mitigates degeneration in a Drosophila model of SCA3. Hum Mol Genet 18, 4843-4852 (2009).
43. Goti, D. et al. A mutant ataxin-3 putative-cleavage fragment in brains of Machado-Joseph disease patients and transgenic mice is cytotoxic above a critical concentration. J Neurosci 24, 10266-10279 (2004).
44. Masino, L., Nicastro, G., Calder, L., Vendruscolo, M. & Pastore, A. Functional interactions as a survival strategy against abnormal aggregation. FASEB J 25, 45-54 (2011).
45. Davranche, A. et al. Huntingtin affinity for partners is not changed by polyglutamine length: aggregation itself triggers aberrant interactions. Hum Mol Genet 20, 2795-2806 (2011).
46. Vachharajani, S. N., Chaudhary, R. K., Prasad, S. & Roy, I. Length of polyglutamine tract affects secondary and tertiary structures of huntingtin protein. Int J Biol Macromol 51, 920-925 (2012).
47. Buchanan, L. E. et al. Structural motif of polyglutamine amyloid fibrils discerned with mixed-isotope infrared spectroscopy. Proc Natl Acad Sci U S A (2014).
48. Heck, B. S., Doll, F. &Hauser, K. Length-dependent conformational transitions of polyglutamine repeats as molecular origin of fibril initiation. Biophys Chem 185, 47-57 (2014).
49. Frost, B. & Diamond, M. I. Prion-like mechanisms in neurodegenerative diseases. Nat Rev Neurosci 11, 155-159 (2010).
50. Orr, H. T. Cell biology of spinocerebellar ataxia. J Cell Biol 197, 167-177 (2012).
51. Bevivino, A. E. & Loll, P. J. An expanded glutamine repeat destabilizes native ataxin-3 structure and mediates formation of parallel beta-fibrils. Proc Natl Acad Sci U S A 98, 11955-11960 (2001).
52. Nagai, Y. et al. A toxic monomeric conformer of the polyglutamine protein. Nat Struct Mol Biol 14, 332-340 (2007).
53. Chow, M. K., Paulson, H. L. & Bottomley, S. P. Destabilization of a nonpathological variant of ataxin-3 results in fibrillogenesis via a partially folded intermediate: a model for misfolding in polyglutamine disease. J Mol Biol 335, 333-341 (2004).
54. Takahashi, T. et al. Soluble polyglutamine oligomers formed prior to inclusion body formation are cytotoxic. Hum Mol Genet 17, 345-356 (2008).
55. Ye, Y., Meyer, H. H. & Rapoport, T. A. The AAA ATPase Cdc48/p97 and its partners transport proteins from the ER into the cytosol. Nature 414, 652-656 (2001).
56. Acs, K. et al. The AAA-ATPase VCP/p97 promotes 53BP1 recruitment by removing L3MBTL1 from DNA double-strand breaks. Nat Struct Mol Biol 18, 1345-1350 (2011).
57. Bao, W. J. et al. Highly efficient expression and purification system of small-size protein domains in Escherichia coli for biochemical characterization. Protein Expr Purif 47, 599-606 (2006).
58. Raasi, S. & Pickart, C. M. Ubiquitin chain synthesis. Methods Mol Biol 301, 47-55 (2005).
59. Zhang, Y. H., Zhou, C. J., Zhou, Z. R., Song, A. X. & Hu, H. Y. Domain Analysis Reveals That a Deubiquitinating Enzyme USP13 Performs Non-Activating Catalysis for Lys63-Linked Polyubiquitin. PLoS One 6, e29362 (2011).
60. Zhou, Z. R., Zhang, Y. H., Liu, S., Song, A. X. & Hu, H. Y. Length of the active-site crossover loop defines the substrate specificity of ubiquitin C-terminal hydrolases for ubiquitin chains. Biochem J 441, 143-149 (2012).